TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has shared an announcement.
ResMed Inc, a company involved in the healthcare sector, has reported a change in beneficial ownership as per a recent filing. Jan De Witte, a director and 10% owner, acquired 1,073 shares of ResMed common stock through Restricted Stock Units (RSUs), which will vest in full by November 2026 or at the next annual stockholders’ meeting. This acquisition reflects the company’s ongoing commitment to aligning its leadership’s interests with those of its shareholders, potentially impacting its market positioning and stakeholder confidence.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$42.00 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
Average Trading Volume: 1,214,271
Technical Sentiment Signal: Buy
Current Market Cap: A$56.69B
For an in-depth examination of RMD stock, go to TipRanks’ Overview page.